A-B Arteether Injection

ALBEQUUB: The Advanced Clinical Standard for Severe and Resistant Malaria

In the management of life-threatening parasitic infections, achieving rapid clearance of the blood-stage pathogens is the highest clinical priority. ALBEQUUB is a professional-grade pharmaceutical intervention engineered for high-impact antimalarial defense. By utilizing a potent semi-synthetic derivative of artemisinin, ALBEQUUB provides a “Precision Strike” against multi-drug resistant strains of malaria.

Produced by Cubic Lifesciences, a leader in the ethical pharmaceutical sector, ALBEQUUB is manufactured under stringent WHO-GMP certified guidelines. It serves as a reliable cornerstone for healthcare providers in hospitals and clinics, particularly for treating severe Plasmodium falciparum malaria and chloroquine-resistant cases.

Product Overview: What is ALBEQUUB?

ALBEQUUB is a sterile injectable solution containing Arteether, a fast-acting blood schizonticide. While many parasites have evolved to survive traditional treatments, the artemisinin-based formula in ALBEQUUB targets the parasite at its most vulnerable stage. This ensures a rapid therapeutic response, making it an essential tool for reducing mortality in acute clinical settings.

Each pack contains 3 Ampoules of 2 ml each, providing a complete and concentrated course for systemic delivery. Designed for Deep Intramuscular (I.M.) Use Only, ALBEQUUB ensures high bioavailability, allowing the medication to reach therapeutic concentrations in the blood almost immediately to halt the progression of the disease.

The Science of Parasitic Eradication: How It Works

ALBEQUUB utilizes a sophisticated biological mechanism to protect the patient’s system:

1. Endoperoxide Activation: The active molecule contains an “endoperoxide bridge” that reacts with the iron in the parasite’s heme.
2. Free Radical Generation: This reaction releases toxic free radicals that specifically target and damage the membranes of the malaria parasite.
3. Rapid Clearance: By destroying the parasite’s proteins and lipids, ALBEQUUB rapidly clears the blood-stage infection, significantly reducing the parasitic load within hours.
4. Neuro-Protective Potential: Its fast-acting nature is critical in preventing the onset of cerebral malaria, a life-threatening complication of the infection.

Key Benefits of ALBEQUUB Injection

• Beats Drug Resistance: Specifically designed to treat malaria that has become resistant to traditional drugs like Chloroquine and Quinine.
• Rapid Fever Resolution: Immediate intramuscular delivery ensures that the patient’s body temperature returns to normal much faster than oral therapy.
• High Clinical Potency: Effectively targets both $\alpha$ and $\beta$ forms of the molecule for a more comprehensive and stable antimalarial effect.
• Short Treatment Duration: The 3-day injection protocol ensures high patient compliance and faster clinical discharge.
• Professional Grade Purity: Manufactured in state-of-the-art facilities with rigorous quality control to ensure maximum stability and patient safety.

Primary Clinical Applications (Indications)

Healthcare specialists and physicians frequently prescribe ALBEQUUB for:

• Severe Plasmodium Falciparum Malaria: Including complicated and life-threatening cases.
• Chloroquine-Resistant Malaria: When first-line oral drugs fail to show results.
• Cerebral Malaria: As a critical intervention to prevent neurological damage.
• Acute Febrile Illness: When malaria is suspected, rapid parasite clearance is mandatory for patient survival.

PCD Pharma Franchise Opportunity

 

As a high-demand, life-saving injectable, ALBEQUUB offers a strategic opportunity for PCD Pharma Franchise partners:

• Critical Care Market Segment: Antimalarials are essential in tropical healthcare markets, ensuring a consistent and vital market demand.
• Ethical Division Branding: Benefit from the expertise, authority, and trust associated with Cubic Lifesciences’ professional standards.
• Exclusive Monopoly Rights: We provide exclusive territory rights to our franchise partners, ensuring a protected and profitable business environment.
• Complete Marketing Kit: Access professional visual aids, product samples, and clinical literature to build strong relationships with physicians and hospitals.

Directions for Professional Use

1. Route: Administered by Deep Intramuscular (I.M.) Injection only. Usually in the upper outer quadrant of the buttock.
2. Dosage: For adults, it is typically given as one 150mg (2ml) injection daily for 3 consecutive days, or as directed by the physician.
3. Visual Inspection: The solution should be clear. Do not use if any particles are visible.
4. Storage: Store in a cool, dry place away from direct sunlight. Do not freeze.

Frequently Asked Questions 

1. What is ALBEQUUB used for?
   ALBEQUUB is a powerful injection used to treat severe and drug-resistant malaria, especially cases caused by the dangerous Plasmodium falciparum parasite.

2. Why is an injection used instead of tablets?
   In severe malaria, the patient may be unable to swallow, or the infection may be spreading too fast. An injection provides 100% absorption and starts killing the parasites instantly.

3. Is it effective against Chloroquine-resistant malaria?
   Yes. ALBEQUUB belongs to the artemisinin class, which is currently the most effective treatment for malaria strains that no longer respond to older drugs.

4. Can it be given Intravenously (I.V.)?
   No. ALBEQUUB is an oil-based injection designed for Deep Intramuscular (I.M.) Use Only. Giving it intravenously can be dangerous.

5. How quickly will the fever go down?
   Most patients show a significant reduction in fever and parasitic count within 24 to 48 hours of the first injection.

6. Does it have any side effects?
   Common side effects include minor pain or swelling at the injection site. Some patients may experience a temporary headache or dizziness. Consult your doctor for a full assessment.

7. Why are there 3 ampoules in a pack?
   A standard clinical course for adults typically requires one injection daily for 3 days to ensure every parasite in the blood is completely eradicated.

8. Why must I finish the full 3-day course?
   Stopping after one injection might make you feel better, but some parasites will survive. These survivors can then cause a relapse or become resistant “superbugs.